Details up front: a sterility test · retatrutide.
This is a planning question. I know what my options are; I do not know how to weigh them.
What I want is the minimum viable version, which I suspect is smaller than what I would design.
What is the minimum version of this that is still defensible?
Start from what you are trying to know — whether a vial contains what the label claims — and purity does not answer that question.
Peak area for a standard of known weight produces a response factor — area per unit mass — which is then applied to the sample peak to infer sample mass.
More usefully, for peptides at 214 nanometres the response is roughly proportional to the number of peptide bonds, so truncation impurities have lower response factors and overestimate content.
The caveat is that content assay costs more than purity, so most people do not do it, which is exactly why it is valuable on the first lot from a new supplier.
The practical summary: if you are ordering from a new supplier, budget for content assay on the first lot.
edited 10 Jul 2024 by deamidation_watch — tightened the wording; no substantive change
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsTwo measures of the same vial can agree on purity and disagree on content by a few per cent, which usually means the content assay used a different standard.
Quantitation against a certified reference material assumes the sample and standard are treated identically through the analytical method, which is why the method for calibration matters as much as the method for measurement.
System suitability for a quantitative method is stricter than for purity because a small systematic error in the standard directly translates into an error in the sample result.
Quantitation against a standard requires that the standard be traceable to a national metrology institute, and certificates for research-grade standards claim that traceability.
The limitation is that a quantitative method is only as good as the standard it uses, and a cheap standard is a false economy.
If a supplier gives you content without the standard's purity, ask them to provide it.
Mechanically, content assay and purity are orthogonal measurements answering orthogonal questions, and the confusion between them is one of the most expensive misreadings in this space.
A content assay is always paired with a purity assay because purity tells you what fraction of the measured mass is the target and content tells you the total measured mass.
The relevant detail is that if the standard and sample have different absorption coefficients at the detection wavelength, the response factors differ and the inference fails.
Where content data have been published from testing services on common peptides, the spread between services on identical material is typically a few per cent.
I would not rely on a content figure from a lab that is not willing to state their standard's purity on request.
Ask for both the purity and the content, and do not accept purity alone.
On the detail: the label claim is usually the gross mass of the lyophilised solid, which is not the same as the content, because the solid contains water, counter-ion and other non-peptide mass.
Comparing content results from different laboratories requires knowing whether they both used certified reference materials or whether one used an in-house standard of unknown provenance.
The relative standard deviation on replicate quantitations of a homogeneous sample should be below two per cent when the method is under control.
One qualification: a single result from a single vial is a point estimate, and repeating the assay on a second aliquot is worth doing if the first result is surprising.
The practical summary: if you are ordering from a new supplier, budget for content assay on the first lot.
Mechanically, a high purity does not guarantee high content because it says nothing about how much of anything is in the vial — a vial could be 99 per cent pure but only half full.
The single most common reason for disagreement between a supplier content figure and an independent assay is using different standards.
Pharmacopoeial guidance on quantitative methods specifies validation steps for linearity, range, accuracy and precision that most research-grade work does not claim to meet.
Worth noting that the standard certificate carries its own uncertainty, usually on the order of two to three per cent, which the sample result inherits.
If a supplier gives you content without the standard's purity, ask them to provide it.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.